FROM Michael de la Merced
Alibaba’s Wooing of Wall Street Fifteen years ago, Jack Ma—the founder of China’s Alibaba—was laughed out of Wall Street. Now the world’s biggest investors are clamoring for a piece of what could be the biggest IPO ever. On Monday, Alibaba held the first of 100 meetings in 10 days, selling itself to potential investors for the first time. It all started in New York City, where 800 people piled into three big rooms at the Waldorf Astoria. One of those in the crowd was Michael de la Merced, reporter for DealBook , a financial news service for the New York Times.
Finger Pointing Follows Facebook's IPO Fiasco Shares of Facebook we initially priced at $38 a share. On the second day of trading, shares tumbled by as much as 18 percent. Fingers of blame are being pointed at Morgan Stanly, Nasdaq and even at Facebook itself. What went wrong with the most highly anticipated high-tech debut in years? Michael de la Merced reports for the Dealbook Section of the New York Times .
What happens when America retreats from the world? Is President Trump taking his "America First" agenda to extremes, withdrawing the country from the international stage on trade and climate change, distancing America from its traditional allies across the Atlantic and even threatening to physically isolate the country through the building of a wall along its southern border? León Krauze guest hosts.
Venezuela spirals into economic and political chaos Venezuela, a country whose potential for prosperity is unmatched, finds itself on the verge of civil war. What sustains the repressive government? With time running out, guest host León Krauze looks at what the international community can do to pull the country from the edge of collapse.
Who's to blame for the opioid crisis? Some of the lawyers who took on Big Tobacco are now going after Big Pharma. It’s all about the deadly epidemic of opioid use. Are the drug companies to blame? What about the users? Later, on today’s Talking Point: making sense of Britain’s upset election.